Strongbridge Biopharma PLC Pre-Tax Profit Margin 2016-2021 | SBBP
Strongbridge Biopharma PLC pre-tax profit margin from 2016 to 2021. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
| Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2021-06-30 | $0.03B | $-0.04B | -117.65% |
| 2021-03-31 | $0.03B | $-0.04B | -137.50% |
| 2020-12-31 | $0.03B | $-0.05B | -145.16% |
| 2020-09-30 | $0.03B | $-0.04B | -144.83% |
| 2020-06-30 | $0.03B | $-0.05B | -192.59% |
| 2020-03-31 | $0.03B | $-0.04B | -172.00% |
| 2019-12-31 | $0.02B | $-0.05B | -218.18% |
| 2019-09-30 | $0.02B | $0.05B | 219.05% |
| 2019-06-30 | $0.02B | $0.04B | 190.00% |
| 2019-03-31 | $0.02B | $0.04B | 238.89% |
| 2018-12-31 | $0.02B | $0.03B | 177.78% |
| 2018-09-30 | $0.02B | $-0.07B | -443.75% |
| 2018-06-30 | $0.01B | $-0.09B | -614.29% |
| 2018-03-31 | $0.01B | $-0.11B | -941.67% |
